C4X Discovery signs potential $402mln licence deal
C4X Discovery Holdings PLC (AIM:C4XD) CEO Clive Dix and chief business officer Bhavna Hunjan speak to Proactive after announcing an exclusive global licence...
Stay updated with breaking news from Clive Dix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
C4X Discovery Holdings PLC (AIM:C4XD) CEO Clive Dix and chief business officer Bhavna Hunjan speak to Proactive after announcing an exclusive global licence...
C4XD will receive milestone payments worth up to $16m ahead of the first clinical trial - News - PharmaTimes
Very few businesses listed on AIM will or indeed ever have hit a home run - this involves discovering, developing and taking to market a unique new treatment.
Very few businesses listed on AIM will or indeed ever have hit a home run - this involves discovering, developing and taking to market a unique new treatment.
Drug development for smaller, innovative life sciences companies is the corporate equivalent of a high wire act. Ensuring the cash taps remain open is one...